Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CBR3-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MRPL12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
WWOX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RANBP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIQK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNRC18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPIDR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GMEB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPRD1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PMCH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VAMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on